Affiliation:
1. Lab of Biochemistry & Molecular Biology, School of Life Sciences, Yunnan University, Kunming 650091, China
Abstract
Breast cancer (BC) has become the most life-threatening cancer to women worldwide, with multiple subtypes, poor prognosis, and rising mortality. The molecular heterogeneity of BC limits the efficacy and represents challenges for existing therapies, mainly due to the unpredictable clinical response, the reason for which probably lies in the interactions and alterations of diverse cell death pathways. However, most studies and drugs have focused on a single type of cell death, while the therapeutic opportunities related to other cell death pathways are often neglected. Therefore, it is critical to identify the predominant type of cell death, the transition to different cell death patterns during treatment, and the underlying regulatory mechanisms in BC. In this review, we summarize the characteristics of various forms of cell death, including PANoptosis (pyroptosis, apoptosis, necroptosis), autophagy, ferroptosis, and cuproptosis, and discuss their triggers and signaling cascades in BC, which may provide a reference for future pathogenesis research and allow for the development of novel targeted therapeutics in BC.
Funder
National Natural Science Foundation of China
the National Natural Science Foundation of China
Yunnan Provincial Science and Technology Department grants
Yunnan Province High-level Scientific and Technological Talent and Innovative Team Selection Project
Reference230 articles.
1. Cancer statistics, 2023;Siegel;CA: A Cancer J. Clin.,2023
2. Global Stage Distribution of Breast Cancer at Diagnosis;Fuentes;JAMA Oncol.,2024
3. Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., and Stanisławek, A. (2021). Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review. Cancers, 13.
4. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade;Weigelt;J. Pathol.,2009
5. Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer;Prat;J. Clin. Oncol.,2013